Loading…
Loading…
XOMA Royalty (NASDAQ: XOMA - Get Free Report) and Nutra Pharma (OTCMKTS:NPHC - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, valuation, institutional ownership, analyst recommendations, profitability, risk and earnings. Volatility and Risk XOMA Royalty has a
The 2024 National Population & Housing Census (NPHC) shows that out of 10.6 million households in Uganda, 155,200 (about 1.5 percent) received remittances during the last 12 months preceding the NPHC 2024. Remittances are household incomes originating from foreign economies, primarily due to the temporary or permanent migration of individuals to those countries. These transfers […] The post REPORT: Buganda, Ankole & Busoga Regions Getting Highest Remittances From Abroad appeared first on Watchdo...
THE Senior Presidential Advisor (SPA) on Poverty Alleviation in Busoga, Mrs. Florence Mutyabule has implored the people in the region to wholly embrace the ongoing National Population and Housing Census (NPHC) as an important national exercise. Mrs. Mutyabule says through the census, the government gets information on the population and its characters which is a […] The post Why SPA Mutyabule believes census is a good tool in combating poverty in Busoga appeared first on Watchdog Uganda...
Nutra Pharma Corp. has reached a bifurcated settlement with the SEC along with its CEO and a Consultant to the company Coral Springs, Florida, March 22, 2024 – Nutra Pharma Corporation (OTC: NPHC), (“Nutra Pharma” or the “Company”) reached a settlement with the U.S. Securities and Exchange Commission (“SEC”) earlier this week.
CORAL SPRINGS, Fla., March 22, 2024 (GLOBE NEWSWIRE) -- Nutra Pharma Corporation (OTC: NPHC), (“Nutra Pharma” or the “Company”) reached a settlement with the U.S. Securities and Exchange Commission (“SEC”) earlier this week.
Nutra Pharma is providing updates regarding their business plans, accounting and compliance Nutra Pharma is providing updates regarding their business plans, accounting and compliance
Nutra Pharma has filed an updated provisional patent for the protection of their intellectual property surrounding the use of RPI-78M and analogs of the drug as potential counter-measures against organophosphate nerve agents Nutra Pharma has filed an updated provisional patent for the protection of their intellectual property surrounding the use of RPI-78M and analogs of the drug as potential counter-measures against organophosphate nerve agents
Nutra Pharma is working with Washington DC-based government affairs consultants and lobbyists to support their Nyloxin® line of pain relief products as well as act as liaisons to governmental agencies Nutra Pharma is working with Washington DC-based government affairs consultants and lobbyists to support their Nyloxin® line of pain relief products as well as act as liaisons to governmental agencies